Related Experiment Video

Updated: May 16, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

MicroRNA Response Elements-Mediated miRNA-miRNA Interactions in Prostate Cancer

Mohammed Alshalalfa1

  • 1Department of Computer Science, University of Calgary, 2500 University Dr. NW, Calgary, AB, Canada T2N 1N4 ; Biotechnology Research Center, Palestine Polytechnic University, Hebron, Palestine.

Advances in Bioinformatics
|November 30, 2012
PubMed

Insights

This study reveals microRNAs (miRNAs) are key regulators in prostate cancer progression. Network analysis identified 11 tumor suppressor miRNAs as potential diagnostic and prognostic biomarkers for this disease.

Area of Science:

  • Molecular Biology
  • Systems Biology
  • Oncology

Background:

  • MicroRNAs (miRNAs) are increasingly recognized for their role in cancer.
  • The precise mechanisms by which miRNAs drive cancer progression and metastasis are not fully understood.
  • Integrating multi-omics data with biological networks is crucial for exploring miRNA functions.

Purpose of the Study:

  • To infer mRNA-mediated miRNA-miRNA interactions using integrated gene expression and miRNA-target data.
  • To characterize the role of microRNA response elements (MREs) in mediating miRNA interactions.
  • To identify key miRNAs involved in prostate cancer progression and metastasis.

Main Methods:

  • Integrated functional miRNA-target interactions with mRNA and miRNA expression data.
  • Constructed a network representing miRNA modulation through common targets.
  • Utilized network analysis to identify regulatory miRNAs and biomarkers in prostate cancer.

Main Results:

  • Identified miRNA-1 as a critical regulator of prostate cancer progression.
  • Discovered 11 miRNAs that function as tumor suppressors.
  • These 11 miRNAs were validated as diagnostic and prognostic biomarkers for prostate cancer.

Conclusions:

  • Network analysis provides a powerful approach for identifying functionally important miRNAs in cancer, surpassing traditional differential expression methods.
  • The identified miRNAs offer potential as therapeutic targets and biomarkers for prostate cancer.
  • This study highlights the utility of systems biology approaches in understanding complex diseases like cancer.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...